Day: September 29, 2020

CloudMD Grants Stock Options

VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), announces the granting of stock options to purchase an aggregate of 525,000 common shares of the Company at an exercise price of $2.15 per share for a five year term.  The stock options were granted pursuant to the Company’s Stock Option Plan and the policies of the TSX Venture Exchange, to directors, officers, and a consultant of the Company.About CloudMD Software & ServicesCloudMD is digitizing the delivery of healthcare by providing patients access to all points of their care from their phone, tablet or desktop computer. The Company offers SAAS based health technology solutions to medical clinics across Canada and has developed proprietary technology...

Continue reading

Surgalign Holdings, Inc. Announces Agreement to Acquire Holo Surgical Inc. and its ARAI™ Digital Surgery Platform

DEERFIELD, Ill., Sept. 29, 2020 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announces that it has entered into a definitive agreement to acquire Holo Surgical Inc., (‘Holosurgical’), a Chicago-based private technology company developing the revolutionary Augmented Reality and Artificial Intelligence platform (‘ARAI™’), to enable digital spine surgery. Total consideration for the transaction is valued at up to $125 million, consisting of consideration valued at $42 million payable at closing in cash and shares plus potential future milestone payments. The transaction is expected to close during the fourth quarter of 2020, subject to customary closing conditions.Holosurgical...

Continue reading

CubeSmart Announces Pricing of 2.000% Senior Unsecured Notes Due 2031

MALVERN, Pa., Sept. 29, 2020 (GLOBE NEWSWIRE) — CubeSmart (NYSE: CUBE) today announced that its operating partnership, CubeSmart, L.P. (the “Operating Partnership”), priced an offering of $450.0 million aggregate principal amount of 2.000% senior unsecured notes due 2031 (the “Notes”) in an underwritten public offering. The Notes were priced at 99.074% of the principal amount with a yield to maturity of 2.100%. The Notes will be fully and unconditionally guaranteed by CubeSmart. The offering is expected to close on October 6, 2020, subject to the satisfaction of customary closing conditions.The Operating Partnership intends to use the net proceeds to redeem all of its outstanding 4.800% Senior Notes due 2022, to repay all of the outstanding indebtedness incurred under its unsecured revolving credit facility maturing in June 2024...

Continue reading

Eton Pharmaceuticals Announces FDA Approval of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) as Replacement Therapy in Pediatric Patients with Adrenocortical Insufficiency

-ALKINDI SPRINKLE is the first and only FDA-approved granular hydrocortisone formulation for adrenocortical insufficiency specifically designed for children-Eton expects ALKINDI SPRINKLE to be available in the fourth quarter of 2020DEER PARK, Ill., Sept. 29, 2020 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved ALKINDI® SPRINKLE (hydrocortisone) oral granules as replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age. ALKINDI SPRINKLE is the first and only FDA-approved granular hydrocortisone formulation for the treatment of adrenocortical insufficiency specifically designed for...

Continue reading

IPL Plastics Inc. Obtains Final Order Approving Plan of Arrangement

MONTREAL, Sept. 29, 2020 (GLOBE NEWSWIRE) — IPL Plastics Inc. (“IPLP” or the “Company”) (TSX: IPLP) today announced that the Company has obtained a final order from the Superior Court of Québec in respect of the previously announced plan of arrangement (the “Arrangement”) pursuant to which Intelligent Packaging Limited Purchaser Inc. (the “Purchaser”), an entity controlled by certain funds managed by Madison Dearborn Partners, LLC, will acquire all of the outstanding shares of the Company (the “Shares”) for C$10.00 in cash per Share.The Company and the Purchaser have now received all required third-party approvals in order to complete the Arrangement. Closing of the Arrangement remains subject to certain customary closing conditions. Assuming the satisfaction of these remaining closing conditions, the transaction is expected to...

Continue reading

Plastiques IPL Inc. obtient l’ordonnance définitive approuvant le plan d’arrangement

MONTRÉAL, 29 sept. 2020 (GLOBE NEWSWIRE) — Plastiques IPL Inc. (« IPLP » ou la « Société ») (TSX : IPLP) a annoncé aujourd’hui avoir obtenu une ordonnance définitive de la Cour supérieure du Québec à l’égard du plan d’arrangement précédemment annoncé (l’« arrangement »), aux termes duquel Intelligent Packaging Limited Purchaser Inc. (l’« acquéreur »), entité contrôlée par certains fonds gérés par Madison Dearborn Partners, LLC (« MDP »), acquerra toutes les actions en circulation de la Société (les « actions ») au prix de 10,00 $ CA en espèces chacune.La Société et l’acquéreur ont maintenant obtenu toutes les approbations de tierces parties requises pour réaliser l’arrangement. La clôture de l’arrangement est encore assujettie à certaines conditions de clôture habituelles. Dans l’hypothèse où ces conditions de clôture restantes...

Continue reading

Strong operating performance continues as Golden Leaf Holdings expects to report a successive record revenue quarter and positive cash flow from operations

TORONTO, Sept. 29, 2020 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” or the “Company”), a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announces expected unaudited results for the three months ended September 30, 2020.The Company anticipates final unaudited revenues for the three months ended September 30, 2020 will be approximately $6.1M with an expected gross margin of 35%. This is the first time in the Company’s history that revenue will exceed $6.0M and represents growth of 13% over the previous quarter and growth of 41% compared to continuing operations from the same quarter in 2019. These results are driven by continued growth in the Company’s Oregon, California and Washington businesses. The Company also...

Continue reading

9F Inc. Reports First Half 2020 Unaudited Financial Results

BEIJING, Sept. 29, 2020 (GLOBE NEWSWIRE) — 9F Inc. (“9F” or “the Company”) (NASDAQ: JFU), a leading digital financial account platform integrating and personalizing financial services in China, today announced its unaudited financial results for the first half ended June 30, 2020.First Half 2020 Operational HighlightsLoan origination volume1 was RMB3.4 billion (US$484.6 million) in the first half of 2020, representing a decrease of 90.4% from RMB35.7 billion in the second half of 2019. Loans funded by institutional funding partners2 accounted for 76.7% of total loan origination volume in the first half of 2020, representing a decrease of 3.0% over the second half of 2019.Number of registered users3 was 110.7 million as of June 30, 2020, representing an increase of 9.1% from 101.4 million as of December 31, 2019.Number of active borrowers4...

Continue reading

Bionano Genomics Announces Continued Expansion of Global Business with Adoption of Saphyr for Next-Generation Cytogenomics in Eastern Europe and Australia

SAN DIEGO, Sept. 29, 2020 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that its Saphyr system has been adopted through reagent-rental agreements by two renowned institutions in Australia and Slovenia: the Royal North Shore Hospital in Northern Sydney, New South Wales, Australia; and the University Medical Center Ljubljana in Ljubljana, Slovenia. Both hospitals aim to assess Saphyr’s potential for diagnosing leukemias as compared to current standards of care, including karyotyping, chromosomal microarray and fluorescence in situ hybridization (FISH).To date, Bionano has successfully driven adoption of its Saphyr system for use in cytogenomic analysis throughout some of the largest markets for clinical research in Europe, North America and Asia. Clinical validation studies in these regions continue to show...

Continue reading

iLOOKABOUT Announces Results of the Annual & Special Meeting of Shareholders and Grant of Deferred Share Units

TORONTO, Sept. 29, 2020 (GLOBE NEWSWIRE) — iLOOKABOUT Corp. (TSXV:ILA; OTCQB:ILATF) (“ILA” or “the Company”) today announced the results of the Annual & Special Meeting of Shareholders (the “Meeting”) held in London, Ontario on September 25, 2020. The shareholders approved the following motions put forth at the Meeting:Election of Allan Bezanson, John C. Drake, Jeff Hack, Peter Hyde, James Kelsey, Phillip Millar, Gerald C. Quinn, Gary Yeoman, and Jeff Young as Directors, each for a term of one year;Re-appointment of KPMG LLP as the Company’s auditor and authorization for the directors to fix the auditors’ remuneration;Re-approval of the Company’s Stock Option Plan set out in Exhibit A of the Management Information Circular dated August 20, 2020; andApproval by way of a special resolution to change the name...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.